175 related articles for article (PubMed ID: 32311881)
1. [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].
Huang R; Li WH; Zhu J; Li CL; Wan HG; Chen LZ
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1164-1168. PubMed ID: 32311881
[No Abstract] [Full Text] [Related]
2. Bronchial arterial chemoembolization with Drug-Eluting beads plus sequential chemotherapy for the treatment of stage III and IV lung squamous cell carcinoma.
Lai L; Xu F; Zhang D; Chen J; Ying X; Chen L; Wu J; Song J; Li W; Ji J; Tu J
Eur J Radiol; 2024 Jun; 175():111398. PubMed ID: 38579540
[TBL] [Abstract][Full Text] [Related]
3. Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study.
He G; Yang K; Zhang X; Pan J; Han A; Gao Z; Li Y; Wang W
Eur J Radiol; 2023 Apr; 161():110747. PubMed ID: 36821958
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer.
Bie Z; Li Y; Li B; Wang D; Li L; Li X
Thorac Cancer; 2019 Sep; 10(9):1770-1778. PubMed ID: 31321919
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting beads bronchial arterial chemoembolization/bronchial arterial infusion chemotherapy with and without PD-1 blockade for advanced non-small cell lung cancer: a comparative single-center cohort study.
Xu S; Li YM; Bie ZX; Li XG
Quant Imaging Med Surg; 2023 Sep; 13(9):6241-6256. PubMed ID: 37711815
[TBL] [Abstract][Full Text] [Related]
6. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization versus conventional bronchial arterial chemoembolization in lung cancer patients with hemoptysis.
Fu Z; Wang C; Wei W; Xiang G; Guan L; Zhan M; Li W; Peng X; Gong Z; Gao B
Future Oncol; 2022 Aug; 18(25):2805-2815. PubMed ID: 35815668
[No Abstract] [Full Text] [Related]
8. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting bead bronchial arterial chemoembolization vs. chemotherapy in treating advanced non-small cell lung cancer: comparison of treatment efficacy, safety and quality of life.
Liu XF; Lin H; Wang Q; Mu M; Pan P; Tian FF; Zhang R; Zhao WG; Bao PT
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2554-2566. PubMed ID: 33829442
[TBL] [Abstract][Full Text] [Related]
10. Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study.
Xu S; Bie ZX; Li YM; Li B; Kong FL; Peng JZ; Li XG
Front Oncol; 2022; 12():851830. PubMed ID: 35371971
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer.
Yu G; Hu J
Postgrad Med; 2020 Aug; 132(6):568-571. PubMed ID: 32400251
[No Abstract] [Full Text] [Related]
12. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma.
Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839
[TBL] [Abstract][Full Text] [Related]
14. Maintenance treatment of immunotherapy after microwave ablation plus drug-eluting bead bronchial arterial chemoembolization for advanced non-small cell lung cancer: a retrospective single-center cohort study.
Xu S; Bie ZX; Li YM; Qi J; Peng JZ; Li XG
Quant Imaging Med Surg; 2024 May; 14(5):3473-3488. PubMed ID: 38720847
[TBL] [Abstract][Full Text] [Related]
15. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.
Liu X; Lin H; Wang Q; Mu M; Pan P; Tian F; Zhang R; Zhao W; Bao P
J Thorac Dis; 2021 Apr; 13(4):2339-2350. PubMed ID: 34012583
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multicenter prospective study.
Zhao YW; Liu S; Qin H; Sun JB; Su M; Yu GJ; Zhou J; Gao F; Wang RY; Zhao T; Zhao GS
Front Oncol; 2023; 13():1110917. PubMed ID: 37124525
[TBL] [Abstract][Full Text] [Related]
18. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
19. Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; García Marcos R; López Briz E; Gómez Muñoz F; Ramos Ruiz J; Martínez Rodrigo JJ; Poveda Andrés JL
Radiologia; 2015; 57(6):496-504. PubMed ID: 25857250
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma.
Liu H; Li Y; Li Z; Han X; Ren K
Front Pharmacol; 2023; 14():1170344. PubMed ID: 37284322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
